COVID-19/Coronavirus

Dealing with children’s mental health comes with a variety of complications and concerns. A comprehensive overview of children’s mental health programs and approaches can provide guidance on further intervention methods. The current state of children’s mental health exhibits many characteristics of a global public health crisis, the effects of which have been augmented by the...

Although mental health symptoms increased during the COVID-19 pandemic, findings show that this increase was short-lived. Changes to mental health were widely reported throughout the COVID-19 pandemic, throughout various locations, socioeconomic levels, and other demographic factors. The purpose of this study, published in the Journal of Affective Disorders, was to analyze these changes throughout 2020,...

The COVID-19 pandemic has had a wide range of effects on the mental health of children, including an increase in anxiety and depression. Certain factors, such as access to social support, were shown to be helpful. The COVID-19 pandemic has caused widespread disruption to many people’s lives, including effects on mental health. Children and adolescents...

The COVID-19 pandemic has resulted in a major disruption to the life of the majority of people, globally, which has affected mental health in many ways. But there are ways to reduce the severity of these effects.. The COVID-19 pandemic has impacted the majority of the human population across the world and has had wide-ranging...

Social inequalities and nutritional disparities place ethnic minorities at a greater risk of developing severe COVID-19 and chronic conditions. National survey data show that, in 2015 29.5% of American adults were obese and 33.4% were overweight. Obesity increases one’s likelihood of developing debilitating chronic degenerative non-communicable diseases (CDNCDs), such as heart disease, diabetes, and several...

Patients who receive chimeric antigen receptor (CAR) T-cell therapy or allogeneic stem cell transplants (allo-SCT) often exhibit some form of immunosuppression as a result of their treatment or transplant. In the era of COVID-19, severe disease has emerged as a grave concern in high-risk CAR T-cell therapy and allo-SCT patients who may have weakened immune...

The implementation of treatment regimens for Hodgkin lymphoma (HL) in the face of COVID-19 is often individualized. Treatments for HL can result in an increased risk of infections and complications due to the immunosuppressive effects of therapy. In addition, standard treatments for HL, including bleomycin and radiation therapy, can increase the risk of pulmonary toxicity....

Incident conditions that may be attributable to COVID-19 are common among adult COVID-19 survivors, according to research published in the May 24 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Lara Bull-Otterson, Ph.D., from the CDC COVID-19 Emergency Response Team, and colleagues used electronic health record data...

The medical community needs new treatments that can lower the chance of COVID-19 worsening in patients. One emerging, promising treatment is molnupiravir—an oral antiviral. To evaluate the safety and efficacy of molnupiravir, researchers for the MOVe-OUT Study Group conducted a phase 3, double-blind, randomized, placebo-controlled trial. Study participants began treatment with molnupiravir 5 days after...